Body Fluid Collection And Diagnostics Market, By Sample, By Product, By Technology, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
Body Fluid Collection And Diagnostics Market size was valued at USD 33,956 Million in 2024, expanding at a CAGR of 6.6% from 2024 to 2032.
Body fluid collection and diagnostics involve obtaining samples of bodily fluids such as blood, urine, saliva, cerebrospinal fluid, and others for medical testing and analysis. These fluids are analyzed to detect infections, monitor organ function, diagnose diseases, and evaluate overall health. The process includes proper sample collection, handling, and laboratory testing using biochemical, microbiological, or molecular techniques. Accurate diagnostics depend on the quality of the collected sample and the methods used for analysis. This field plays a critical role in clinical decision-making, disease prevention, and treatment planning, contributing significantly to personalized and evidence-based healthcare.
Body Fluid Collection And Diagnostics Market- Market Dynamics
Rising Prevalence of Chronic and Infectious Diseases
The growing incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases, along with the persistent threat of infectious diseases, is driving demand for body fluid collection and diagnostics. Early and accurate diagnosis is essential for effective treatment and disease management, increasing the reliance on fluid-based diagnostic tests. Additionally, the spread of viral infections like COVID-19 has further highlighted the need for rapid and reliable testing methods. This trend is pushing healthcare providers and diagnostic companies to invest in advanced technologies, boosting market growth and innovation in diagnostic tools.
Body Fluid Collection And Diagnostics Market- Key Insights
According to our research analyst, the global Body Fluid Collection And Diagnostics Market is expected to develop at a CAGR of approximately 6.6% between 2024-2032.
Segmented by Sample in 2023, the Blood category dominated the market.
Based on Product Type, the Tests/Services segment generated the most income in 2023.
On the basis of region, in 2023, North America was the region with the highest revenue.
Body Fluid Collection And Diagnostics Market- Segmentation Analysis:
The global Body Fluid Collection And Diagnostics Market is divided into Five categories: Sample, Product, Technology, Application and Region.
By sample, the body fluid collection and diagnostics market is segmented into blood, saliva, urine, and cerebrospinal fluid. Each sample type plays a distinct role in diagnostic testing, depending on the disease or condition being assessed. Blood is the dominant segment due to its comprehensive diagnostic value, as it contains various biomarkers that reflect the body's physiological and pathological states. Blood tests are widely used for routine health checkups, disease screening, monitoring organ function, and detecting infections, cancer markers, and metabolic disorders. The ease of integration with automated laboratory systems and the growing use of blood-based tests in personalized medicine further reinforce its leading position in the market. Meanwhile, saliva and urine are gaining traction for their non-invasive nature and potential in point-of-care testing.
By product, the body fluid collection and diagnostics market is categorized into tests/services, kits & consumables, and instruments. Among these, the tests/services segment holds the dominant share, driven by the high demand for diagnostic testing across hospitals, laboratories, and point-of-care settings. This segment includes a broad range of analytical services such as blood chemistry panels, urinalysis, and molecular diagnostics, which are essential for disease detection, treatment monitoring, and preventive care. The increasing burden of chronic diseases, rising health awareness, and the expansion of diagnostic laboratories globally have fueled the growth of this segment. Additionally, advancements in testing methodologies and the growing trend of outsourcing diagnostic services to specialized labs further support the segment's leadership in the market.
Body Fluid Collection And Diagnostics Market- Geographical Insights
Geographically, the Body Fluid Collection And Diagnostics Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.
North America holds a dominant position in the body fluid collection and diagnostics market, primarily due to its advanced healthcare infrastructure, high healthcare spending, and widespread adoption of cutting-edge diagnostic technologies. The United States contributes significantly, with a strong presence of key market players, robust reimbursement frameworks, and growing demand for personalized medicine. Additionally, the rising prevalence of chronic and infectious diseases and the increasing emphasis on early diagnosis and preventive care further boost market growth. Government initiatives supporting research and development in diagnostics also strengthen the region's market position.
Asia Pacific is emerging as a dominant region in the body fluid collection and diagnostics market, fueled by its large patient population, improving healthcare infrastructure, and rising awareness about early disease detection. Countries such as China, India, and Japan are leading contributors, driven by increasing healthcare investments, urbanization, and the adoption of modern diagnostic technologies. Additionally, the growing burden of lifestyle-related diseases and infectious conditions is creating a high demand for efficient diagnostic solutions. Favorable government policies, expanding diagnostic laboratories, and a rapidly developing biotech sector further enhance the region's growth prospects in this market.
Body Fluid Collection And Diagnostics Market- Competitive Landscape:
The body fluid collection and diagnostics market is dominated by established industry leaders like Thermo Fisher Scientific, Bio-Rad Laboratories, Illumina, and QIAGEN, known for their extensive product portfolios and strong focus on innovation. These companies invest heavily in research and development to enhance diagnostic accuracy, speed, and safety while complying with global regulatory standards. The competitive environment encourages continuous technological advancements, including liquid biopsy and molecular diagnostics, improving early disease detection. New entrants are introducing cutting-edge solutions, further driving market growth. Collaborations and acquisitions among key players foster innovation and expand market reach, benefiting healthcare providers and patients worldwide.
Recent Developments:
In March 2024, Thermo Fisher Scientific launched a new next-generation sequencing platform designed to accelerate clinical diagnostics with higher throughput and improved accuracy.
In January 2025, Illumina, Inc. acquired a leading liquid biopsy startup to strengthen its non-invasive cancer detection portfolio, enhancing its position in precision oncology diagnostics.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories
Illumina, Inc
Guardant Health
QIAGEN
Johnson & Johnson
Laboratory Corporation of America Holdings
Biocept Inc
F. Hoffmann-La Roche Ltd.
MDxHealth SA.
Others
GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET, BY SAMPLE - MARKET ANALYSIS, 2019 - 2032
Blood
Saliva
Urine
Cerebrospinal Fluid
GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032
Tests/Services
Kits & Consumables
Instruments
GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032
Next Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Fluorescence In Situ Hybridization (FISH)
Others
GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032
Diagnostics & Monitoring
Therapeutic Decision Making
Prognostics & Screening
GLOBAL BODY FLUID COLLECTION AND DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
1. Body Fluid Collection and Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Body Fluid Collection and Diagnostics Market Snippet by Sample
2.1.2. Body Fluid Collection and Diagnostics Market Snippet by Product
2.1.3. Body Fluid Collection and Diagnostics Market Snippet by Technology
2.1.4. Body Fluid Collection and Diagnostics Market Snippet by Application
2.1.5. Body Fluid Collection and Diagnostics Market Snippet by Country
2.1.6. Body Fluid Collection and Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Body Fluid Collection and Diagnostics Key Market Trends
3.1. Body Fluid Collection and Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Body Fluid Collection and Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Body Fluid Collection and Diagnostics Market Opportunities
3.4. Body Fluid Collection and Diagnostics Market Future Trends
4. Body Fluid Collection and Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Body Fluid Collection and Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Body Fluid Collection and Diagnostics Market Landscape
6.1. Body Fluid Collection and Diagnostics Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players' Analysis
6.2.2. Emerging Players' Analysis
7. Body Fluid Collection and Diagnostics Market - By Sample
7.1. Overview
7.1.1. Segment Share Analysis, By Sample, 2023 & 2032 (%)
7.1.2. Blood
7.1.3. Saliva
7.1.4. Urine
7.1.5. Cerebrospinal Fluid
8. Body Fluid Collection and Diagnostics Market - By Product
8.1. Overview
8.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
8.1.2. Tests/Services
8.1.3. Kits & Consumables
8.1.4. Instruments
9. Body Fluid Collection and Diagnostics Market - By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
9.1.2. Next Generation Sequencing (NGS)
9.1.3. Polymerase Chain Reaction (PCR)
9.1.4. Fluorescence in situ hybridization (FISH)
9.1.5. Others
10. Body Fluid Collection and Diagnostics Market - By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
10.1.2. Diagnostics & Monitoring
10.1.3. Therapeutic Decision Making
10.1.4. Prognostics & Screening
11. Body Fluid Collection and Diagnostics Market- By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Body Fluid Collection and Diagnostics Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Sample, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)